Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biontech Se ADR (NQ: BNTX )

85.42 -1.83 (-2.10%)
Streaming Delayed Price Updated: 3:36 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biontech Se ADR

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
54 55 Next >
FDA Adds Rare Bleeding Risk To Johnson & Johnson's COVID-19 Vaccine Fact Sheet
The FDA amended the fact sheet for Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine to include a rare risk of immune thrombocytopenia. This condition can lead to... 
Via Benzinga
IBD/TIPP Poll: Will Pediatric Shots Extend Pfizer, BioNTech Streak?
More than six in 10 people support Covid shots for young children. 
Via Investor's Business Daily
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On Restricted Coverage For Its Alzheimer's Drug Biogen... 
Via Benzinga
BioNTech Partners With London-Based AI Developer To Predict COVID-19 Variants
BioNTech SE (NASDAQ: BNTX) said it’s working with London-based AI developer InstaDeep to develop a new computational method that analyzes sequencing data and... 
Via Benzinga
The Week Ahead In Biotech (Jan 10-15): JPMorgan Healthcare Conference Front And Center, Preannouncements Keep Coming
Biotech stocks came under selling pressure along with the broader market, as rate hike fears seized Wall Street. The news flow, however, was scanty. Last week, the Food and Drug... 
Via Benzinga
Expert Ratings For BioNTech
Over the past 3 months, 6 analysts have published their opinion on BioNTech (NASDAQ: 
Via Benzinga
Why Codex DNA Shares Are Trading Higher Today?
Pfizer Inc (NYSE: PFE) has signed on two partners in an effort to become an mRNA powerhouse. Pfizer will offer milestone payments of over $100 million to ... 
Via Benzinga
Pfizer Makes Foray Into CRISPR, Inking $1.35 Billion Deal With Beam Therapeutics
The companies hope to cure diseases of the liver, muscle and central nervous system. 
Via Investor's Business Daily
Is The Launch Of A Fund A Sell Signal For An Asset?
Healthcare, commodities, and now Bitcoin? 
Via Talk Markets
What Does the Selling of Bonds Tell Us About Investor Sentiment?
While equity index futures are still pointing to a lower open on Wednesday, they did trim some losses after the ADP Nonfarm Employment report showed strong gains in December. More... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,... 
Via Benzinga
After Successful COVID-19 Vaccine, Pfizer, BioNTech Come Together For mRNA-Based Shingles Vaccine
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have announced a new research, development, and commercialization collaboration to develop a potential first... 
Via Benzinga
Pfizer Stock Continues Its Downfall Despite New CDC Guidance For Covid Booster
Now, recipients of the Pfizer and BioNTech vaccine can get a booster at five months. 
Via Investor's Business Daily
Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced an exclusive option agreement and research collaboration with Kansas State University (K-State) to... 
Via Benzinga
FDA Allows Covid Boosters For Young Teens; But Vaccine Stocks Crumble
Now, children age 12-15 can receive Pfizer and BioNTech's Covid booster shot. 
Via Investor's Business Daily
FDA Approves Pfizer's COVID-19 Booster For Age 12 To 15
The FDA has authorized the use of a third dose of the Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) COVID-19 vaccine for children aged... 
Via Benzinga
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
China-based Sinovac Biotech Ltd's (NASDAQ: SVA) two-dose COVID-19 vaccine followed by a booster Pfizer Inc (NYSE: PFE) -BioNTech SE (NASDAQ: BNTX)... 
Via Benzinga
Best Stocks Of 2021: Meme Stocks, Biotechs Highlight Broad Sector Strength
The list features stocks from diverse sectors as the economy recovers from the pandemic. 
Via Investor's Business Daily
BioNTech Jumps As FDA's Next Potential Covid Booster Decision Looms
The FDA could potentially authorize Covid boosters for young teens on Monday. 
Via Investor's Business Daily
Market Trend: Erratic And Unreliable
Given the risks of covid variants and hefty price rises, the stock market should not be as buoyant as it is. 
Via Talk Markets
Pfizer, BioNTech Extend Losses As FDA Reportedly Mulls Boosters For Young Teens
Vaccine stocks extended their losses Wednesday despite reports U.S. officials could soon authorize a Covid booster shot for younger teens. 
Via Investor's Business Daily
Pfizer's CEO Shows You How To Get 'Impossible' Tasks Done Fast
Scientists told the Pfizer CEO they could create a vaccine in 18 months. But Albert Bourla knew they could work even faster. 
Via Investor's Business Daily
BioNTech Whale Trades For December 27
A whale with a lot of money to spend has taken a noticeably bullish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 12 strange trades. If we... 
Via Benzinga
Pfizer-BioNTech Reveals Updated Longer-Term Data On COVID-19 Shot In Adolescents
Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have submitted longer-term follow-up data from the Phase 3 trial of the COVID-19 mRNA vaccine in... 
Via Benzinga
7 Safe Stocks Immune From Omicron and Future Covid-19 Variants
Investors are increasingly searching for safe stocks to buy, just in case new Covid-19 variants lead to a slowdown in the global economy. 
Via InvestorPlace
Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron
A three-dose course of AstraZeneca Plc's (NASDAQ: AZN) COVID-19 vaccine is effective against the omicron coronavirus variant, data from an Oxford University lab... 
Via Benzinga
Looking At BioNTech's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 11 strange trades. If we... 
Via Benzinga
MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?
Vaccine stocks aren't enjoying a good morning today, but there's plenty of reason to suspect that they are in for a better year in 2022. 
Via InvestorPlace
How Moderna Is Leading The Omicron Battle As Novavax Wins Key Endorsement
Moderna's authorized booster led to a 37-fold increase in neutralizing antibodies. 
Via Investor's Business Daily
Weekly Commentary: Pandemic Risks Rising - Again
It was another volatile week for global markets, stoked by a combination of central bank meetings and heightened COVID anxieties. 
Via Talk Markets
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
54 55 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.